Endo Pharmaceuticals, 7.25% 15jan2022, USD (FIGI BBG0027GGWR5, WKN A1GW2J)
国際債券, Senior Unsecured
国際債券, Senior Unsecured
|
Endo Pharmaceuticals Solutions Inc. develops products to treat conditions in urology and endocrinology in the United States. The company was formerly known as Indevus Pharmaceuticals Inc. As a result of the acquisition of Indevus Pharmaceuticals Inc. ...
Endo Pharmaceuticals Solutions Inc. develops products to treat conditions in urology and endocrinology in the United States. The company was formerly known as Indevus Pharmaceuticals Inc. As a result of the acquisition of Indevus Pharmaceuticals Inc. by Endo Pharmaceuticals, Inc., Indevus Pharmaceuticals Inc.'s name was changed. The company was founded in 1988 and is based in Chadds Ford, Pennsylvania. As of March 18, 2009, Endo Pharmaceuticals Solutions Inc. operates as a subsidiary of Endo Pharmaceuticals Inc.
|
|
|
|
|
|
|
|
|
最も包括的なデータベースを探索
1 000 000
債券
80 234
株
167 970
ETF&投資信託
70 000
インデックス
最も効率的な方法でポートフォリオを追跡